| Χρονικό πλαίσιο | Προβλεπόμενη τιμή | Το παρελθόν | Ιστορικός | Διορατικότητα |
|---|---|---|---|---|
| Αύριο | $1.41 ▲ +1.77% | Εχθές | $1.38 ▼ -0.74% | Tomorrow's Telomir Pharmaceuticals Inc. Common Stock (TELO) setup is anchored to $1.39 and targets $1.41 (+1.77%). The near-term read is upside; watch $1.43 / $1.35 because daily realized volatility is about 8.00%. |
Tomorrow's Telomir Pharmaceuticals Inc. Common Stock (TELO) setup is anchored to $1.39 and targets $1.41 (+1.77%). The near-term read is upside; watch $1.43 / $1.35 because daily realized volatility is about 8.00%. | ||||
| Εβδομάδα | $1.47 ▲ +5.50% | Την περασμένη εβδομάδα | $1.36 ▼ -2.31% | The 7-day Telomir Pharmaceuticals Inc. Common Stock model moves from $1.36 to $1.47 (+5.50%). It gives upside momentum context for this stock, so breaks around $1.43 / $1.35 matter more than a single tick. |
The 7-day Telomir Pharmaceuticals Inc. Common Stock model moves from $1.36 to $1.47 (+5.50%). It gives upside momentum context for this stock, so breaks around $1.43 / $1.35 matter more than a single tick. | ||||
| Μήνας | $1.55 ▲ +11.71% | τον περασμένο μήνα | $1.32 ▼ -4.92% | The 1-month Telomir Pharmaceuticals Inc. Common Stock target is $1.55 (+11.71%), compared with the live reference near $1.39. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Telomir Pharmaceuticals Inc. Common Stock target is $1.55 (+11.71%), compared with the live reference near $1.39. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Ετος | $1.68 ▲ +21.03% | Πέρυσι | $1.27 ▼ -8.83% | The 1-year Telomir Pharmaceuticals Inc. Common Stock scenario points to $1.68 (+21.03%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Telomir Pharmaceuticals Inc. Common Stock scenario points to $1.68 (+21.03%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Χρόνια | $1.99 ▲ +42.86% | Πριν 5 Χρόνια | $1.14 ▼ -18.00% | The 5-year Telomir Pharmaceuticals Inc. Common Stock view is $1.99 (+42.86%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Telomir Pharmaceuticals Inc. Common Stock view is $1.99 (+42.86%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Δείκτης | Αξία | Σύνθημα |
|---|---|---|
| Price | $1.39 | Mid |
| Daily Change | -6.08% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 70% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $1.39 | Daily Change | -6.08% |
| Market Cap | $47.79M | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.